probenecid has been researched along with Kahler Disease in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raaijmakers, HG | 1 |
| Van Den Bosch, G | 1 |
| Boezeman, J | 1 |
| De Witte, T | 1 |
| Raymakers, RA | 1 |
1 other study available for probenecid and Kahler Disease
| Article | Year |
|---|---|
Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitors.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, CD34; ATP Binding Cassette Trans | 2002 |